The Goldman Sachs Group cut shares of Cue Health (NASDAQ:HLTH – Get Rating) from a buy rating to a neutral rating in a research note released on Friday, The Fly reports. Separately, BTIG Research decreased their price objective on Cue Health from $5.00 to $3.00 in a report on Monday, May 15th. Cue Health Trading […]